Prince Joshua S.
SEC CIK 1998663 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics, Inc. | COO | 15.2K | — | — | 4 | 2024-06-28 | 2025-12-31 |
Most active insiders at VTGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Prince Joshua S. | COO | — | — |
| 2 | Adler Reid G. | CLO | — | — |
| 3 | Tressler Nick B. | CFO | — | — |
| 4 | Singh Shawn | Pres, CEO, Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-05 | 2025-12-31 | VTGN | Vistagen Therapeutics, Inc. | Prince Joshua S. | COO | A - Grant | $0.56 | +4,386 | 15.2K | +40% | +$2,456 | |
| 2025-07-01 | 2025-06-30 | VTGN | Vistagen Therapeutics, Inc. | Prince Joshua S. | COO | A - Grant | $1.70 | +4,882 | 10.9K | +82% | +$8,299 | |
| 2025-01-13 | 2024-12-31 | VTGN | Vistagen Therapeutics, Inc. | Prince Joshua S. | COO | A - Grant | $2.51 | +3,310 | 5,981 | +124% | +$8,308 | |
| 2024-07-02 | 2024-06-28 | VTGN | Vistagen Therapeutics, Inc. | Prince Joshua S. | COO | A - Grant | $2.96 | +2,671 | 2,671 | New | +$7,906 |
Purchase Sale Sale after option exercise All abbreviations